EDIT:NASDAQ
Editas Medicine Inc
$2.36
arrow_upward
+0.64%(+0.015) 1D
Oct 19, 11:19:15 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
$2.38
High
$2.41
Low
$2.32
Mkt. cap
363.22M
Avg. vol.
3.01M
Volume
255.34K
52-wk high
$4.28
52-wk low
$1.66
EPS
-$0.74
Beta
2.00
Shares outstanding
153.58M
No. of employees
87
Open
$2.38
High
$2.41
Low
$2.32
Mkt. cap
363.22M
Avg. vol.
3.01M
Volume
255.34K
52-wk high
$4.28
52-wk low
$1.66
EPS
-$0.74
Beta
2.00
Shares outstanding
153.58M
No. of employees
87
News stories
From web sources and news partners
Mahoning Matters
·
2 minutes ago
S&P 500, Nasdaq climb as AI-linked stocks recover ahead of earnings
HDFC Sky
·
38 minutes ago
Nasdaq Jumps 259 Points to 26,399 as Intel Surges 5.5% and AI Stocks Rebound After Brutal Selloff
TipRanks
·
31 minutes ago
Dow Jones Steady as AI Stocks Rebound from Selloff
TradingView
·
1 hour ago
The Dow Jones Index Opens 0.08% Lower
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc